Association of Baseline Smoking Status with Long-Term Prognosis in Patients Who Underwent Percutaneous Coronary

Ru Liu1, Zhan Gao1, Huanhuan Wang1

  • 1Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Insights

In coronary artery disease (CAD) patients undergoing percutaneous coronary intervention (PCI), baseline smoking status did not significantly impact long-term prognosis. Risks for major adverse coronary events, including death and stroke, were similar between current smokers and nonsmokers after two years.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Public Health

Background:

  • Limited data exists on the "smoker's paradox" in Chinese populations with coronary artery disease (CAD).
  • Understanding the impact of baseline smoking status on long-term prognosis after percutaneous coronary intervention (PCI) is crucial.

Purpose of the Study:

  • To analyze the association between baseline smoking status and the long-term prognosis of CAD patients who have undergone PCI.
  • To investigate the presence of the "smoker's paradox" in a large Chinese cohort.

Main Methods:

  • A cohort of 10,724 consecutive patients undergoing PCI between January and December 2013 was analyzed.
  • Two-year clinical outcomes, including major adverse coronary events (MACE) such as all-cause death, revascularization, myocardial infarction (MI), and stroke, were compared between current smokers and nonsmokers.

Main Results:

  • Current smokers (57.1%) were younger, predominantly male, and had fewer comorbidities than nonsmokers (42.9%).
  • No significant difference was observed in 2-year all-cause death rates between groups.
  • Nonsmokers had higher rates of stroke and bleeding, while current smokers had a higher rate of revascularization; however, multivariable analysis showed no independent association of smoking with any endpoint.

Conclusions:

  • Baseline smoking status did not independently predict 2-year outcomes in CAD patients after PCI.
  • Risks for all-cause death, MACE, MI, revascularization, stroke, and bleeding were similar between current smokers and nonsmokers.
  • The study suggests that the "smoker's paradox" may not be a significant factor in this Chinese population undergoing PCI.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
196
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
185
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
173
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
203